CHAI
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

CHAI Trademark

Serial Number: 99841144

CHAI is a trademark filed by Bill, Hillary & Chelsea Clinton Foundation on May 22, 2026. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Bill, Hillary & Chelsea Clinton Foundation

New York, NY 10019

Entity Type: 03

Trademark Details

Filing Date

May 22, 2026

Registration Date

Not Registered

Goods & Services

Financial advisory services in the fields of program administration for health financing, health budget analysis, and health insurance design; administration of donor-funded grant programs in the field of global health; lending and financing services, namely, providing credit facilities to facilitate access to pharmaceutical and medical innovations.

Business management consulting services in the field of health systems administration; supply chain management consulting services for health commodities; market research services in the fields of pharmaceuticals, diagnostics, vaccines, and medical devices; market analysis services, namely, compiling and analyzing market data relating to pricing, supply, and access to health commodities; procurement services, namely, negotiating prices and contractual terms for health commodities on behalf of third parties; demand aggregation services for health commodity procurement; business administration services for donor-funded global health programs.

Public health consulting and advisory services for governments, ministries of health, and public health stakeholders; advisory services to governments for the development of regulatory frameworks for artificial intelligence in healthcare; health policy planning and technical advisory services; operational support services for the implementation and management of national health programs; regulatory affairs consulting services for pharmaceutical, diagnostic, and medical device products, namely, advising on regulatory approval pathways; assistive technology needs assessment and screening services for individuals with disabilities; advisory services to governments relating to the development of national assistive technology policies and supply chain frameworks; technical advisory and facilitation services for pharmaceutical technology transfer and generic medicine development.

Education and training services, namely, conducting training programs, workshops, seminars, and field-based mentorship for healthcare workers, government health officials, and health system managers; developing and providing training-of-trainers programs in the field of healthcare; developing and distributing educational materials in the fields of public health and health systems management; publishing research reports, policy briefs, market analyses, and technical fact sheets in the fields of global health and health policy.

Scientific research services in the fields of public health, epidemiology, and health economics; health economics research, namely, modeling the costs and cost-effectiveness of health interventions; geospatial analysis and mapping services in the field of public health; design and development of software platforms for health data management, health facility performance monitoring, and disease campaign management; design and development of data visualization tools and dashboards for health resource planning; technology consulting services in the field of artificial intelligence applications for health systems, including computer-aided diagnostics and clinical decision support; consulting services to developers of artificial intelligence software, namely, providing healthcare and global health domain expertise to inform the design and development of artificial intelligence systems; quality assurance consulting services for pharmaceutical and diagnostic product manufacturers.

Filing History

APPLICATION FILING RECEIPT MAILED
May 22, 2026 MAFR
NEW APPLICATION ENTERED
May 22, 2026 NWAP